The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

This publication has 29 references indexed in Scilit:

• A double‐blind, placebo‐controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
  Scandinavian Journal of Gastroenterology, 2004
• The importance 5HT4 receptor-mediated mechanisms in the regulation of colonic hypersensitivity in rats
  Gastroenterology, 2003
• Subject's Global Assessment of Relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials
  Journal of Clinical Epidemiology, 2003
• Tegaserod, a 5‐HT₄ receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects
  Alimentary Pharmacology & Therapeutics, 2001
• Antinociceptive properties of HTF 919 (tegaserod), a 5-HT4 receptor partial agonist, on colorectal distension in rats
  Gastroenterology, 2000
• Functional bowel disorders and functional abdominal pain
  Gut, 1999
• Variability of gastrointestinal transit in healthy women and men.
  Gut, 1996
• Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate.
  BMJ, 1990
• Non-colonic features of irritable bowel syndrome.
  Gut, 1986